Boothbay Fund Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Boothbay Fund Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-130	Closed	-$1.33M	–	983
2019 Q2	$1.33M	Hold	130	–	–	0.12%	210
2019 Q1	$1.48M	Buy	+130	New	+$9.55K	0.14%	160
2018 Q3	–	Sell	-574	Closed	-$4.75M	–	1016
2018 Q2	$4.75M	Buy	+574	New	+$44.3K	0.41%	49

Boothbay Fund Management's ONCE Position: Q4 2019 in Review

Boothbay Fund Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 76,557 shares — an estimated $7.42M sold.

Boothbay Fund Management first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $7.42M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Boothbay Fund Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Boothbay Fund Management sold 76,557 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $7.42M.
Boothbay Fund Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Boothbay Fund Management's Spark Therapeutics, Inc. Common Stock position peaked at $7.42M in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.